Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07525245

Effectiveness of Large Language Model-Based Chatbot Among Parents of Junior High School Girls in Improving Human Papillomavirus (HPV) Vaccine Awareness, Intention and Vaccination Rates

A Study on the Effectiveness of Large Language Model-Based Chatbot Interventions Among Parents of Junior High School Girls in Improving Human Papillomavirus (HPV) Vaccine Awareness, Intention and Vaccination Rates

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
18,000 (estimated)
Sponsor
Xiamen University · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

This is an interventional study targeting parents of junior high school girls. The primary objective of the study is to evaluate the effectiveness of a vaccine chatbot in improving HPV vaccination rates among parents' junior high school girls. The secondary objectives are to evaluate the effectiveness in improving vaccine awareness and vaccination intention among parents. All participants will be enrolled and randomly assigned to four groups: (1) vaccine chatbot plus scientific videos, (2) vaccine chatbot only, (3) scientific videos only, and (4) a control group (no intervention). The chatbot will provide immediate, validated answers to participants' HPV vaccine-related questions. The scientific videos will cover content related to HPV vaccine safety, efficacy, and other relevant information. The study will compare changes in HPV vaccine awareness, vaccination intention, and vaccination behavior between the intervention groups and the control group after the intervention to evaluate whether the three intervention strategies enhance HPV vaccine awareness, vaccination intention, and vaccination uptake.

Conditions

Interventions

TypeNameDescription
DEVICEScientific videosProvide scientific videos related to HPV vaccine
DEVICEVaccine chatbotProvide vaccine chatbot to answer HPV vaccine questions

Timeline

Start date
2026-05-06
Primary completion
2027-12-31
Completion
2027-12-31
First posted
2026-04-13
Last updated
2026-04-15

Source: ClinicalTrials.gov record NCT07525245. Inclusion in this directory is not an endorsement.